Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 to 65

Using brain stimulation to improve control in gambling disorder

Official title: Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation

Run by CNS Onlus · NCT03669315 · Data updated 2026-11-12

This study is testing whether a type of brain stimulation can help people with gambling disorder gain better control over their gambling behavior.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorCNS Onlus
Academic / other
Locations1 site (Florence)
StatusRecruiting
StartedMay 20, 2018
Main results expectedDecember 1, 2019
Study endsDecember 1, 2019
Registry record updatedSeptember 13, 2018
Trial IDNCT03669315 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with a DSM-5 diagnosis of Gambling Disorder.

Probably not a fit

Patients with significant psychiatric comorbidities or a history of severe mental disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of theta burst stimulation on patients diagnosed with Gambling Disorder. In a randomized double-blind placebo-controlled design, 40 participants will receive either active or sham transcranial magnetic stimulation (TMS) to the pre-supplementary motor area (pre-SMA) over two weeks. The study aims to explore the neural mechanisms underlying gambling behavior by combining TMS with multimodal structural and functional MRI, as well as behavioral assessments. The goal is to identify changes in brain connectivity that correlate with clinical improvements in inhibitory control and symptom severity.

Why it matters

Potential benefit: If successful, this approach could enhance inhibitory control and reduce gambling impulses in affected individuals.

How similar studies have gone: Previous studies using TMS for various psychiatric conditions have shown promising results, suggesting potential efficacy for this novel application in Gambling Disorder.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. DSM-5 diagnosis of Gambling Disorder
2. Age between 18 and 65 years

Exclusion Criteria:

1. any additional current psychiatric comorbidity, except for nicotine addiction;
2. a lifetime DSM-5 diagnosis of schizophrenia or other psychotic syndromes, substance dependence or substance abuse, including alcohol, bipolar I or II disorder, mental disorder due to a general medical condition;
3. serious suicide risk;
4. illness duration less than two years;
5. hospitalization in the last 6 months;
6. the inability to receive TMS because of metallic implants, or history of seizures (personal or family history of seizure in first degree relatives);
7. any major medical disease;
8. pregnancy or nursing of an infant;
9. the inability or refusal to provide written informed consent.

Where it's running

  • CNSOnlus, Institute of Neuroscience
    Florence, Italy
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.